A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (Q49124072)

18 February 2018

title

A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (English)

1 reference

18 February 2018

amyotrophic lateral sclerosis

main subject

neuroimaging

0 references

0 references

author

Francesco Saccà

1

1 reference

18 February 2018

Mario Quarantelli

2

1 reference

18 February 2018

Arturo Brunetti

11

1 reference

18 February 2018

Marco Salvatore

14

1 reference

18 February 2018

Vincenzo Brescia Morra

object named as

Vincenzo Brescia Morra

12

0 references

author name string

Carlo Rinaldi

3

1 reference

18 February 2018

Tecla Tucci

4

1 reference

18 February 2018

Raffaele Piro

5

1 reference

18 February 2018

Gaetano Perrotta

6

1 reference

18 February 2018

Barbara Carotenuto

7

1 reference

18 February 2018

Angela Marsili

8

1 reference

18 February 2018

Vincenzo Palma

9

1 reference

18 February 2018

Giuseppe De Michele

10

1 reference

18 February 2018

Alessandro Filla

13

1 reference

18 February 2018

publication date

25 June 2011

1 reference

18 February 2018

published in

Journal of Neurology

1 reference

18 February 2018

volume

259

1 reference

18 February 2018

issue

1

1 reference

18 February 2018

page(s)

132-138

1 reference

18 February 2018

Growth hormone secretion is impaired in amyotrophic lateral sclerosis.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Recombinant growth hormone treatment of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Peripheral growth hormone induces cell proliferation in the intact adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Insulin resistance in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6146-2

The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency

1 reference

12 December 2020

Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients

1 reference

12 December 2020

Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

12 December 2020

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

12 December 2020

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

12 December 2020

Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis

1 reference

12 December 2020

The IGF-I generation test revisited: a marker of GH sensitivity

1 reference

12 December 2020

Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans1

1 reference

12 December 2020

10.1007/S00415-011-6146-2

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

1009189398

0 references

1 reference

18 February 2018